Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Medical Contrast Agent market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Medical Contrast Agent market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Segmented by End User/Segment
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Other Applications
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Subhra Pharma Private
Spago Nanomedical
Nanopet Pharma
Lantheus Medical Imaging
Guerbet Group
GE Healthcare
Daiichi Sankyo
CMC Contrast
Bracco Imaging
Bayer
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Medical Contrast Agent Market Status and Forecast (2016-2027) 1.3.2 Global Medical Contrast Agent Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Medical Contrast Agent Supply by Company 2.1 Global Medical Contrast Agent Sales Volume by Company 2.2 Global Medical Contrast Agent Sales Value by Company 2.3 Global Medical Contrast Agent Price by Company 2.4 Medical Contrast Agent Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Medical Contrast Agent Market Status by Category 3.1 Medical Contrast Agent Category Introduction 3.1.1 Barium-based Contrast Media 3.1.2 Iodinated Contrast Media 3.1.3 Gadolinium-based Contrast Media 3.1.4 Microbubble Contrast Media 3.2 Global Medical Contrast Agent Market by Category 3.2.1 Global Medical Contrast Agent Sales Volume by Category (2016-2021) 3.2.2 Global Medical Contrast Agent Sales Value by Category (2016-2021) 3.2.3 Global Medical Contrast Agent Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Medical Contrast Agent Market Status by End User/Segment 4.1 Medical Contrast Agent Segment by End User/Segment 4.1.1 Cardiovascular Disorders 4.1.2 Neurological Disorders 4.1.3 Gastrointestinal Disorders 4.1.4 Cancer 4.1.5 Nephrological Disorders 4.1.6 Musculoskeletal Disorders 4.1.7 Other Applications 4.2 Global Medical Contrast Agent Market by End User/Segment 4.2.1 Global Medical Contrast Agent Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Medical Contrast Agent Sales Value by End User/Segment (2016-2021) 4.2.3 Global Medical Contrast Agent Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Medical Contrast Agent Market Status by Region 5.1 Global Medical Contrast Agent Market by Region 5.1.1 Global Medical Contrast Agent Sales Volume by Region 5.1.2 Global Medical Contrast Agent Sales Value by Region 5.2 North America Medical Contrast Agent Market Status 5.3 Europe Medical Contrast Agent Market Status 5.4 Asia Pacific Medical Contrast Agent Market Status 5.5 Central & South America Medical Contrast Agent Market Status 5.6 Middle East & Africa Medical Contrast Agent Market Status6 North America Medical Contrast Agent Market Status 6.1 North America Medical Contrast Agent Market by Country 6.1.1 North America Medical Contrast Agent Sales Volume by Country (2016-2021) 6.1.2 North America Medical Contrast Agent Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Medical Contrast Agent Market Status 7.1 Europe Medical Contrast Agent Market by Country 7.1.1 Europe Medical Contrast Agent Sales Volume by Country (2016-2021) 7.1.2 Europe Medical Contrast Agent Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Medical Contrast Agent Market Status 8.1 Asia Pacific Medical Contrast Agent Market by Country 8.1.1 Asia Pacific Medical Contrast Agent Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Medical Contrast Agent Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Medical Contrast Agent Market Status 9.1 Central & South America Medical Contrast Agent Market by Country 9.1.1 Central & South America Medical Contrast Agent Sales Volume by Country (2016-2021) 9.1.2 Central & South America Medical Contrast Agent Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Medical Contrast Agent Market Status 10.1 Middle East & Africa Medical Contrast Agent Market by Country 10.1.1 Middle East & Africa Medical Contrast Agent Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Medical Contrast Agent Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Medical Contrast Agent Manufacturing Cost Analysis 11.5 Medical Contrast Agent Sales Channel and Distributors Analysis 11.5.1 Medical Contrast Agent Sales Channel 11.5.2 Medical Contrast Agent Distributors 11.6 Medical Contrast Agent Downstream Major Buyers12 Global Medical Contrast Agent Market Forecast by Category and by End User/Segment 12.1 Global Medical Contrast Agent Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Medical Contrast Agent Forecast by Category 12.2.1 Global Medical Contrast Agent Sales Volume Forecast by Category 12.2.2 Global Medical Contrast Agent Sales Value Forecast by Category 12.2.3 Global Medical Contrast Agent Price Forecast by Category 12.3 Global Medical Contrast Agent Forecast by End User/Segment 12.3.1 Global Medical Contrast Agent Sales Volume Forecast by End User/Segment 12.3.2 Global Medical Contrast Agent Sales Value Forecast by End User/Segment 12.3.3 Global Medical Contrast Agent Price Forecast by End User/Segment13 Global Medical Contrast Agent Market Forecast by Region/Country 13.1 Global Medical Contrast Agent Market Forecast by Region (2022-2027) 13.1.1 Global Medical Contrast Agent Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Medical Contrast Agent Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Subhra Pharma Private 14.1.1 Company Information 14.1.2 Medical Contrast Agent Product Introduction 14.1.3 Subhra Pharma Private Medical Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Spago Nanomedical 14.2.1 Company Information 14.2.2 Medical Contrast Agent Product Introduction 14.2.3 Spago Nanomedical Medical Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Nanopet Pharma 14.3.1 Company Information 14.3.2 Medical Contrast Agent Product Introduction 14.3.3 Nanopet Pharma Medical Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Lantheus Medical Imaging 14.4.1 Company Information 14.4.2 Medical Contrast Agent Product Introduction 14.4.3 Lantheus Medical Imaging Medical Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Guerbet Group 14.5.1 Company Information 14.5.2 Medical Contrast Agent Product Introduction 14.5.3 Guerbet Group Medical Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 GE Healthcare 14.6.1 Company Information 14.6.2 Medical Contrast Agent Product Introduction 14.6.3 GE Healthcare Medical Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Daiichi Sankyo 14.7.1 Company Information 14.7.2 Medical Contrast Agent Product Introduction 14.7.3 Daiichi Sankyo Medical Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 CMC Contrast 14.8.1 Company Information 14.8.2 Medical Contrast Agent Product Introduction 14.8.3 CMC Contrast Medical Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Bracco Imaging 14.9.1 Company Information 14.9.2 Medical Contrast Agent Product Introduction 14.9.3 Bracco Imaging Medical Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Bayer 14.10.1 Company Information 14.10.2 Medical Contrast Agent Product Introduction 14.10.3 Bayer Medical Contrast Agent Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis15 Conclusion16 Methodology